Operative Difficulties and Post-Surgical Outcomes in "Super Morbidly Obese" (Class 4+) Patients

极度病态肥胖(4级及以上)患者的手术难度及术后结果

阅读:2

Abstract

Study DesignRetrospective Cohort Study.ObjectiveObesity rates have risen over recent decades, with many affected individuals experiencing degenerative spine conditions. A parallel increase in spine surgeries has raised questions about how to best optimize care in obese patients. Those with extremely high BMI (>50), classified as "Super Morbidly Obese (SMO)", may face higher risks of poor surgical outcomes. To better understand the challenges in treating this population, we compared complications, and operative characteristics between morbidly obese (MO), and SMO.MethodsA single-institution retrospective review was conducted on patients with a BMI over 40 who underwent a neurosurgical procedure from 2017 to 2023. Inclusion criteria were (1) patient age >17 years, (2) BMI >40, and (3) surgical interventions performed by a member of the department of neurological surgery. Demographic, clinical, surgical, and post-operative follow-up were analyzed.ResultsPatients were split into SMO (BMI 50+) and MO (BMI 40-50) groups. SMO received more intra-operative imaging radiation (P = 0.0169), experienced longer hospital stays (P < 0.0005) and experienced more post-operative complications than MO patients (P = 0.008). SMO patients experienced more complications when discharged home than their MO counterparts (P = 0.0002, RR = 12.2 [2.7-53.4]).ConclusionRisk in SMO spine surgery can be reduced through weight loss, modified surgical approaches, and better discharge planning. Regardless of comorbidities, SMO patients discharged home face higher complication rates than MO patients and may benefit from early discussions about skilled nursing placement. Larger studies are needed to better assess surgical management and outcomes in this population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。